MIMS Competitors and Similar CompaniesClear all

Eisai's competitors and similar companies include Shield Therapeutics.
Eisai
Eisai
Eisai (エーザイ株式会社) is a research-based human healthcare company that discovers, develops, packages, and markets pharmaceutical products.
Shield Therapeutics
Shield Therapeutics
Shield Therapeutics is a pharmaceutical company developing and commercializing late-stage, mineral-derived pharmaceuticals.
Founding Date
Founding Date
1941
Founding Date
2008
Type
Type
Public
Type
Private
Tags
Locations
Locations
Tokyo, JP HQ
Melbourne, AU
Wien, AT
Leuven, BE
Mississauga, CA
see more
Locations
Gateshead, GB HQ
Berlin, DE
Wollerau, CH
London, GB
Wilmington, US
Employees
Employees
11,067
Employees
701% increase

Financial

Revenue (est.)
Revenue (est.)
¥789.4b (FY, 2025)
Revenue (est.)
£11.9m (FY, 2018)
Cost of goods
Cost of goods
¥128.9b (FY, 2025)
Cost of goods
£311k (FY, 2018)
Gross profit
Gross profit
¥677.7b (FY, 2025)
Gross profit
£11.6m (FY, 2018)
Net income
Net income
¥48.1b (FY, 2025)
Net income
(£1.8m) (FY, 2018)
For sources of this data, please see the company profile

View Company Profiles

Shield Therapeutics
HQ
Gateshead, GB
Employees
70↑ 1% increase

Shield Therapeutics is a pharmaceutical company developing and commercializing late-stage, mineral-derived pharmaceuticals.

View company